In addition, DM2 patients showed elevated neutrophil counts, fasting glucose levels, and decreased estimated glomerular filtration rates, as well as an increasing trend in inflammatory markers, such as the neutrophil-to-lymphocyte ratio (NLR) and the systemic inflammatory response index (SIRI).
← all excerpts
Circulating Bacterial DNA as a Novel Blood-Based Biomarker in Type 2 Diabetes Mellitus (DM2): Results from the PROMOTERA Study.
1
—
—